US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Capstead Mortgage

6.50

+0.0000

Volume:- -

Turnover:- -

Market Cap:629.69M

PE:9.25

High:6.50

Open:6.50

Low:6.50

Close:6.50

Loading ...

Overview Company News Filings

Palisade Bio CMO Mitch Jones, MD, PhD, to Present at 8th Annual Antifibrotic Drug Development (AFDD) Summit

73% of enterprises have launched AI, including generative AI, across marketing with 52% of deployments achieving business value: Infosys CMO Radar

SheVerified: Rachel Conlan, CMO of Binance, on Amplifying Women’s Voices and Pushing Crypto into the Mainstream

Cosmos Health Issues Letter to Shareholders

Belite Bio Advances in Tinlarebant Trials, Appoints New CMO

Press Release: BrainsWay Reports Third Quarter 2024 Financial Results and Operational Highlights

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update

HITIQ Limited Strengthens Leadership with New CMO

Keurig Dr Pepper names Drew Panayiotou as CMO U.S. Refreshment Beverages

Press Release: Keurig Dr Pepper Appoints Drew Panayiotou as Chief Marketing Officer, U.S. Refreshment Beverages

Press Release: Bolt Projects Reports Q3 2024 Financial Results

Tyra Biosciences Reports Third Quarter 2024 Financial Results and Highlights

PROS Appoints Colleen Langevin as Chief Marketing Officer

Elanco Animal Health Reports Third Quarter 2024 Results

BRIEF-Former Microsoft CMO Joins Lumen's Board Of Directors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CMO/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CMO"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CMO\",,,,,undefined,":{"symbol":"CMO","market":"US","secType":"STK","nameCN":"Capstead Mortgage","latestPrice":6.5,"timestamp":1683316800000,"preClose":6.5,"halted":0,"volume":0,"delay":0,"changeRate":0,"change":0,"floatShares":94511941,"shares":96875560,"eps":0.70279,"lyrEps":-1.561156,"pbRate":1.01,"amount":0,"amplitude":0,"dividePrice":0.6,"prevYearClose":5.81},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CMO\",,,,,undefined,":{"symbol":"CMO","floatShares":94511941,"roa":"1.05%","roe":"9.73%","lyrEps":-1.561156,"shares":96875560,"dividePrice":0.6,"high":6.5,"amplitude":0,"preClose":6.5,"low":6.5,"week52Low":5.06,"pbRate":"1.01","week52High":7,"institutionHeld":0.6556,"latestPrice":6.5,"eps":0.70279,"divideRate":0.092308,"volume":0,"delay":0,"ttmEps":0.70279,"open":6.5,"prevYearClose":5.81},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CMO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-10-19","symbol":"CMO","reason":null,"defaultRemindTime":1634650200000,"announcedDate":"2021-10-14","type":"delisting","dateTimestamp":1634616000000},{"market":"US","date":"2021-09-29","symbol":"CMO","amount":0.0725,"defaultRemindTime":1632922200000,"name":"卡帕史丹抵押","recordDate":"2021-10-15","payableDate":"2021-09-30","currency":"USD","type":"dividend","dateTimestamp":1632888000000},{"market":"US","date":"2021-07-28","symbol":"CMO","fiscalQuarterEnding":"2021/06","expectedEps":0.14,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1627444800000,"reportTimeType":"post","actualEps":0.09},{"market":"US","date":"2021-06-29","symbol":"CMO","amount":0.15,"defaultRemindTime":1624973400000,"name":"卡帕史丹抵押","recordDate":"2021-07-20","payableDate":"2021-06-30","currency":"USD","type":"dividend","dateTimestamp":1624939200000},{"market":"US","date":"2021-04-28","symbol":"CMO","fiscalQuarterEnding":"2021/03","expectedEps":0.15,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1619582400000,"reportTimeType":"post","actualEps":0.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CMO\",market:\"US\",,,undefined,":[{"executeDate":"2017-03-29","recordDate":"2017-03-31","paymentDate":"2017-04-20","value":0.21,"currency":"USD"},{"executeDate":"2017-06-28","recordDate":"2017-06-30","paymentDate":"2017-07-20","value":0.21,"currency":"USD"},{"executeDate":"2017-09-28","recordDate":"2017-09-29","paymentDate":"2017-10-20","value":0.19,"currency":"USD"},{"executeDate":"2017-12-28","recordDate":"2017-12-29","paymentDate":"2018-01-19","value":0.19,"currency":"USD"},{"executeDate":"2018-03-28","recordDate":"2018-03-29","paymentDate":"2018-04-20","value":0.16,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CMO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CMO\",params:#withValueCompare:true,withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CMO","date":"2021-10-15","current":7.640996,"percent":0.314859,"low":-22.34847,"twenty":-2.345067,"median":8.952272,"eighty":9.977375,"high":12.421044,"avg":5.832951,"sd":6.794752,"marketCap":663597586},"quantilePoints":[{"date":"2020-03-20","current":-8.384079,"twenty":7.238212,"median":9.013153,"eighty":9.961637,"marketCap":296276574},{"date":"2020-03-27","current":-13.719402,"twenty":7.223837,"median":9.003038,"eighty":9.961637,"marketCap":484816212},{"date":"2020-04-03","current":-8.91988,"twenty":7.18316,"median":8.990183,"eighty":9.961637,"marketCap":315210711},{"date":"2020-04-09","current":-13.802627,"twenty":7.179535,"median":8.982272,"eighty":9.960108,"marketCap":487757247},{"date":"2020-04-17","current":-12.793344,"twenty":7.148263,"median":8.969195,"eighty":9.961637,"marketCap":452091203},{"date":"2020-04-24","current":-12.902456,"twenty":7.078887,"median":8.959161,"eighty":9.961637,"marketCap":455946992},{"date":"2020-05-01","current":-13.338903,"twenty":7.056071,"median":8.952272,"eighty":9.961637,"marketCap":471370146},{"date":"2020-05-08","current":-2.058678,"twenty":7.030259,"median":8.94381,"eighty":9.961637,"marketCap":478117776},{"date":"2020-05-15","current":-1.959065,"twenty":7.014387,"median":8.94381,"eighty":9.961637,"marketCap":454983045},{"date":"2020-05-22","current":-2.125087,"twenty":7.006826,"median":8.94381,"eighty":9.961637,"marketCap":493540930},{"date":"2020-05-29","current":-2.100184,"twenty":6.985716,"median":8.94381,"eighty":9.961637,"marketCap":487757247},{"date":"2020-06-05","current":-2.353368,"twenty":6.971413,"median":8.94381,"eighty":9.961637,"marketCap":546558022},{"date":"2020-06-12","current":-2.324314,"twenty":6.94205,"median":8.94381,"eighty":9.961637,"marketCap":539810392},{"date":"2020-06-19","current":-2.270357,"twenty":6.929442,"median":8.94381,"eighty":9.961637,"marketCap":527279080},{"date":"2020-06-26","current":-2.282809,"twenty":6.908337,"median":8.94381,"eighty":9.961637,"marketCap":530170921},{"date":"2020-07-02","current":-2.241303,"twenty":6.880197,"median":8.94381,"eighty":9.961637,"marketCap":520531450},{"date":"2020-07-10","current":-2.212249,"twenty":6.861906,"median":8.94381,"eighty":9.961637,"marketCap":513783820},{"date":"2020-07-17","current":-2.407326,"twenty":6.832359,"median":8.94381,"eighty":9.961637,"marketCap":559089335},{"date":"2020-07-24","current":-2.43638,"twenty":6.818289,"median":8.94381,"eighty":9.961637,"marketCap":565836965},{"date":"2020-07-31","current":-2.552595,"twenty":6.804219,"median":8.94381,"eighty":9.961637,"marketCap":592827484},{"date":"2020-08-07","current":-4.061327,"twenty":6.783114,"median":8.94381,"eighty":9.961637,"marketCap":593282683},{"date":"2020-08-14","current":-4.200006,"twenty":6.760603,"median":8.94381,"eighty":9.961637,"marketCap":613541116},{"date":"2020-08-21","current":-4.094346,"twenty":6.628662,"median":8.94381,"eighty":9.961637,"marketCap":598106119},{"date":"2020-08-28","current":-4.173591,"twenty":6.575134,"median":8.94381,"eighty":9.961637,"marketCap":609682367},{"date":"2020-09-04","current":-4.008497,"twenty":6.549871,"median":8.94381,"eighty":9.961637,"marketCap":585565185},{"date":"2020-09-11","current":-3.902836,"twenty":6.541892,"median":8.94381,"eighty":9.961637,"marketCap":570130188},{"date":"2020-09-18","current":-4.094346,"twenty":6.521948,"median":8.94381,"eighty":9.961637,"marketCap":598106119},{"date":"2020-09-25","current":-3.816987,"twenty":6.508651,"median":8.94381,"eighty":9.961637,"marketCap":557589253},{"date":"2020-10-02","current":-3.757553,"twenty":6.490036,"median":8.94381,"eighty":9.961637,"marketCap":548907068},{"date":"2020-10-09","current":-3.889628,"twenty":6.462113,"median":8.94381,"eighty":9.961637,"marketCap":568200813},{"date":"2020-10-16","current":-3.757553,"twenty":6.43552,"median":8.94381,"eighty":9.961637,"marketCap":548907068},{"date":"2020-10-23","current":-3.744345,"twenty":6.408927,"median":8.94381,"eighty":9.961637,"marketCap":546977693},{"date":"2020-10-30","current":-3.374963,"twenty":6.396659,"median":8.94381,"eighty":9.961637,"marketCap":493017910},{"date":"2020-11-06","current":-4.133915,"twenty":6.382334,"median":8.94381,"eighty":9.961637,"marketCap":496875857},{"date":"2020-11-13","current":-4.454995,"twenty":6.375541,"median":8.94381,"eighty":9.961637,"marketCap":535468156},{"date":"2020-11-20","current":-4.559347,"twenty":6.370072,"median":8.94381,"eighty":9.961637,"marketCap":548010654},{"date":"2020-11-27","current":-4.703833,"twenty":6.339686,"median":8.94381,"eighty":9.961637,"marketCap":565377189},{"date":"2020-12-04","current":-4.888454,"twenty":6.329062,"median":8.94381,"eighty":9.961637,"marketCap":587567761},{"date":"2020-12-11","current":-4.735941,"twenty":6.329062,"median":8.94381,"eighty":9.961637,"marketCap":569236419},{"date":"2020-12-18","current":-4.800157,"twenty":6.329062,"median":8.94381,"eighty":9.961637,"marketCap":576954879},{"date":"2020-12-24","current":-4.679752,"twenty":6.329062,"median":8.94381,"eighty":9.961637,"marketCap":562482766},{"date":"2020-12-31","current":-4.615536,"twenty":6.329062,"median":8.94381,"eighty":9.961637,"marketCap":554764306},{"date":"2021-01-08","current":-4.615536,"twenty":6.368159,"median":8.946403,"eighty":9.966491,"marketCap":554764306},{"date":"2021-01-15","current":-4.567374,"twenty":6.368159,"median":8.946403,"eighty":9.966491,"marketCap":548975461},{"date":"2021-01-22","current":-4.639617,"twenty":6.368159,"median":8.946403,"eighty":9.966491,"marketCap":557658729},{"date":"2021-01-29","current":-4.005977,"twenty":6.368159,"median":8.946403,"eighty":9.966491,"marketCap":519066429},{"date":"2021-02-05","current":-4.147452,"twenty":6.382334,"median":8.952088,"eighty":9.972174,"marketCap":537397771},{"date":"2021-02-12","current":-4.955732,"twenty":6.382334,"median":8.952088,"eighty":9.972174,"marketCap":642129114},{"date":"2021-02-19","current":-4.818073,"twenty":6.376126,"median":8.952088,"eighty":9.972174,"marketCap":624292194},{"date":"2021-02-26","current":-4.279938,"twenty":6.309203,"median":8.952088,"eighty":9.972174,"marketCap":554564395},{"date":"2021-03-05","current":-4.459202,"twenty":-1.961556,"median":8.95218,"eighty":9.973908,"marketCap":577792223},{"date":"2021-03-12","current":-4.735568,"twenty":-2.042907,"median":8.95218,"eighty":9.973908,"marketCap":613601791},{"date":"2021-03-19","current":-4.705691,"twenty":-2.110146,"median":8.952272,"eighty":9.975641,"marketCap":609730487},{"date":"2021-03-26","current":-4.743038,"twenty":-2.149161,"median":8.95218,"eighty":9.973908,"marketCap":614569617},{"date":"2021-04-01","current":-4.653405,"twenty":-2.212249,"median":8.95218,"eighty":9.973908,"marketCap":602955703},{"date":"2021-04-09","current":-4.776135,"twenty":-2.241303,"median":8.952272,"eighty":9.975641,"marketCap":618858144},{"date":"2021-04-16","current":-4.798558,"twenty":-2.282809,"median":8.952272,"eighty":9.975641,"marketCap":621763582},{"date":"2021-04-23","current":-4.746237,"twenty":-2.322654,"median":8.952272,"eighty":9.975641,"marketCap":614984228},{"date":"2021-04-30","current":6.63356,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":623700540},{"date":"2021-05-07","current":6.674762,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":627574456},{"date":"2021-05-14","current":6.551155,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":615952707},{"date":"2021-05-21","current":6.674762,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":627574456},{"date":"2021-05-28","current":6.654161,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":625637498},{"date":"2021-06-04","current":6.674762,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":627574456},{"date":"2021-06-11","current":6.952877,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":653723392},{"date":"2021-06-18","current":6.695363,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":629511415},{"date":"2021-06-25","current":6.520253,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":613047270},{"date":"2021-07-02","current":6.437849,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":605299437},{"date":"2021-07-09","current":6.149433,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":578182022},{"date":"2021-07-16","current":6.221537,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":584961376},{"date":"2021-07-23","current":6.27304,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":589803771},{"date":"2021-07-30","current":7.259662,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":630479894},{"date":"2021-08-06","current":7.105569,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":617097317},{"date":"2021-08-13","current":7.228271,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":627753628},{"date":"2021-08-20","current":7.217116,"twenty":-2.345067,"median":8.952272,"eighty":9.975641,"marketCap":626784873},{"date":"2021-08-27","current":7.618687,"twenty":-2.345897,"median":8.952272,"eighty":9.978311,"marketCap":661660074},{"date":"2021-09-03","current":7.730234,"twenty":-2.345897,"median":8.952272,"eighty":9.978311,"marketCap":671347630},{"date":"2021-09-10","current":7.707924,"twenty":-2.345897,"median":8.952272,"eighty":9.978311,"marketCap":669410119},{"date":"2021-09-17","current":7.730234,"twenty":-2.345897,"median":8.952272,"eighty":9.978311,"marketCap":671347630},{"date":"2021-09-24","current":7.69677,"twenty":-2.345897,"median":8.952272,"eighty":9.978311,"marketCap":668441364},{"date":"2021-10-01","current":7.46252,"twenty":-2.345897,"median":8.952272,"eighty":9.978311,"marketCap":648097496},{"date":"2021-10-08","current":7.741389,"twenty":-2.345067,"median":8.952272,"eighty":9.977375,"marketCap":672316386},{"date":"2021-10-15","current":7.640996,"twenty":-2.345067,"median":8.952272,"eighty":9.977375,"marketCap":663597586}],"customCompares":[],"updateTime":1742087890289},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CMO\",pageSize:16,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2483806335","title":"Palisade Bio CMO Mitch Jones, MD, PhD, to Present at 8th Annual Antifibrotic Drug Development (AFDD) Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2483806335","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483806335?lang=en_us&edition=fundamental","pubTime":"2024-11-14 22:00","pubTimestamp":1731592800,"startTime":"0","endTime":"0","summary":"Presentation to highlight advances in fibrostenotic Crohn’s Disease and the potential of localized PDE4 inhibition Carlsbad,CA, Nov.  14, 2024  (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/14/2981267/0/en/Palisade-Bio-CMO-Mitch-Jones-MD-PhD-to-Present-at-8th-Annual-Antifibrotic-Drug-Development-AFDD-Summit.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMMF","BK4211","MD","CMO","BK4196"],"gpt_icon":0},{"id":"2483072802","title":"73% of enterprises have launched AI, including generative AI, across marketing with 52% of deployments achieving business value: Infosys CMO Radar","url":"https://stock-news.laohu8.com/highlight/detail?id=2483072802","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483072802?lang=en_us&edition=fundamental","pubTime":"2024-11-13 18:29","pubTimestamp":1731493740,"startTime":"0","endTime":"0","summary":"AI-fluent CMOs are becoming a transformative force in business; 62% see their influence growing over broader corporate decisions as their AI implementations look to improve brand experience, as well as efficiency and effectiveness in marketing.The Infosys CMO Radar 2024 found that while most CMOs are engaging in AI across all their main marketing activities, almost half (48%) of AI deployments struggle to deliver business value. It uses these insights to categorize CMOs as Leaders (13%), Learners (60%) or Laggards (27%) in AI fluency, based on their ability to deliver business value from AI across multiple marketing activities.96% of marketing leaders have deployed AI in at least one marketing activity.52% of AI marketing deployments generate business value.30% of marketing leaders have deployed AI in all seven key marketing activities.Embed AI solutions into business and marketing processes: Leading CMOs ensure their teams can access real-time insights from data and immediately adjust","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/AQ0BXR3VweCT2zOBB9JCAQ--~B/aD0xNDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/cc3918b53e07da38b4289189f178bf5c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/AQ0BXR3VweCT2zOBB9JCAQ--~B/aD0xNDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/cc3918b53e07da38b4289189f178bf5c"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/73-enterprises-launched-ai-including-102900795.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/73-enterprises-launched-ai-including-102900795.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0066902890.USD","LU0287143357.SGD","LU0431992006.USD","LU0862451753.SGD","INFY","LU0531971678.HKD","LU0164881194.USD","LU1366334578.USD","CMO","LU0868486357.SGD","BK4134","BK4585","LU1323998911.USD","LU0791590937.USD","LU1267930656.SGD","LU0197229882.USD","BK4523","LU0898667661.SGD","BK4535","LU0890818403.SGD","LU2087589342.USD","LU0831103253.SGD","LU0333810181.USD","LU1102505762.USD","IE00B7N09G41.SGD","IE00B0JY6M65.USD","LU0791591158.USD","LU1805238398.USD","LU2265009873.SGD","BK4588","LU0708995666.HKD","LU0536402901.SGD","LU1366334651.USD","LU1804176565.USD","IE00BYTNYM70.SGD","IE00B3M56506.USD","LU0231203729.USD","BK4533"],"gpt_icon":0},{"id":"2483003297","title":"SheVerified: Rachel Conlan, CMO of Binance, on Amplifying Women’s Voices and Pushing Crypto into the Mainstream","url":"https://stock-news.laohu8.com/highlight/detail?id=2483003297","media":"BE[IN]CRYPTO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483003297?lang=en_us&edition=fundamental","pubTime":"2024-11-13 02:00","pubTimestamp":1731434400,"startTime":"0","endTime":"0","summary":"Rachel Conlan scales Binance’s marketing by leveraging agile, user-focused strategies to expand its global community.She focuses on empowering women in crypto, aiming to onboard 500 women by 2025 through educational initiatives.By aligning with regulators and hosting 1,500+ events annually, Binance fosters trust and education in the crypto space.Rachel Conlan’s career journey has been anything but conventional. With over two decades of experience spanning marketing, media, and entertainment, Conlan now serves as the Chief Marketing Officer of Binance, one of the world’s leading cryptocurrency exchanges. Starting her career in the world of advertising, she honed her skills working with global Fortune 500 brands and guiding legacy companies through digital transformations.In this interview, Conlan delves into her strategic approach to scaling Binance’s global marketing efforts, her insights on empowering women in crypto, and her mission to foster a more inclusive and decentralized financ","market":"us","thumbnail":"https://beincrypto.com/wp-content/uploads/2024/11/Rachel20Conlan_1600x900-850x478.png.webp","type":0,"news_type":0,"thumbnails":["https://beincrypto.com/wp-content/uploads/2024/11/Rachel20Conlan_1600x900-850x478.png.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://beincrypto.com/sheverified-binance-rachel-conlan/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"beincrypto_highlight","symbols":["APT.USD.CC","TON.USD.HKCC","APT.USD.HKCC","CMO","TON.USD.CC","RNDR.USD.HKCC"],"gpt_icon":0},{"id":"2483039906","title":"Cosmos Health Issues Letter to Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2483039906","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483039906?lang=en_us&edition=fundamental","pubTime":"2024-11-13 01:00","pubTimestamp":1731430800,"startTime":"0","endTime":"0","summary":"CHICAGO, IL / ACCESSWIRE / November 12, 2024 / Cosmos Health Inc.  , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that its Chief Executive Officer, Greg Siokas, has issued the following letter to the Company's shareholders.As highlighted above, we have been actively expanding our asset base while simultaneously deleveraging. Taking a step back to provide a broader view, from 2018 to June 2024, Cosmos has achieved the following milestones:. Increased Total Assets by 194%, from $20.69 million to $60.83 million. Decreased Total Debt, adjusted for lines of credit, by 71%, from $13.51 million to $3.95 million. Increased Revenue by 50%, from $37.08 million to $55.58 million. Increased Gross Profit by 74%, from $2.41 million to $","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/7POFxltJsYSEsQ0hPz.vQg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/dc2ff1403d630a7ef4814c3bbeacc3bb","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/7POFxltJsYSEsQ0hPz.vQg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/dc2ff1403d630a7ef4814c3bbeacc3bb"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cosmos-health-issues-letter-shareholders-170000629.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["COSM","UAE","BK4135","BK4175","CNS","CMO"],"gpt_icon":0},{"id":"2483080332","title":"Belite Bio Advances in Tinlarebant Trials, Appoints New CMO","url":"https://stock-news.laohu8.com/highlight/detail?id=2483080332","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483080332?lang=en_us&edition=fundamental","pubTime":"2024-11-12 23:48","pubTimestamp":1731426515,"startTime":"0","endTime":"0","summary":"Belite Bio, Inc. ADR (BLTE) has released an update. Belite Bio, Inc. has reported its third-quarter 2024 financial results, highlighting significan...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/belite-bio-advances-in-tinlarebant-trials-appoints-new-cmo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/belite-bio-advances-in-tinlarebant-trials-appoints-new-cmo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLTE","BK4007","CMO"],"gpt_icon":0},{"id":"2482190705","title":"Press Release: BrainsWay Reports Third Quarter 2024 Financial Results and Operational Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2482190705","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482190705?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:30","pubTimestamp":1731414600,"startTime":"0","endTime":"0","summary":"Robust 26% Year-over-Year Revenue Growth in Q3 2024. Raising Full-Year 2024 Revenue Guidance to $40-41 Million and Initiating Profitability Guidance. BURLINGTON, Mass. and JERUSALEM, Israel, Nov. 12, 2024  -- BrainsWay Ltd.  , a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today reported third quarter 2024 financial results and provided an operational update.-- For the three months ended September 30, 2024, revenues were $10.5. million, a 26% increase compared to the same period in 2023.-- Gross margin for the third quarter of 2024 was 74%, steady from the same. -- Operating income for the third quarter of 2024 was $0.3 million, compared. to a loss of $0.1 million for the same period in 2023.-- Net income for the third quarter of 2024 was $0.7 million, compared to a. net loss of $0.2 million for the third quarter of 2023.-- Adjusted EBITDA1 for the third quarter of 2024 was approximately $1.1. deposits totaled $48.4 million, reflecting ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","BK4082","BK4555","BK4099","BK4585","BK4588","CMO","BWAY","TM"],"gpt_icon":0},{"id":"2482470695","title":"CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2482470695","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482470695?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:20","pubTimestamp":1731414000,"startTime":"0","endTime":"0","summary":"Strengthened Cash, Strategic Refocus and Pipeline Progress Define Transformative Quarter. 400 million upfront payment from restructured GSK collaboration reflected in financials, cash position increased to 551 million; expected cash runway re-affirmed into 2028. CVGBM Phase 1 glioblastoma study showed 77% of patients with antigen-specific T-cell responses; data presented at ESMO, SITC and SNO. New off-the-shelf program for squamous non-small cell lung cancer started, expected to enter Phase 1 in H2 2025. New preclinical prophylactic vaccine program for urinary tract infections initiated, supported by positive preclinical data versus protein-based vaccines. Positive Phase 2 data from seasonal influenza program licensed to GSK demonstrated strong immune responses against challenging influenza B as well as A strains; program progressing to Phase 3, which will be associated with significant milestone payment. Corporate redesign on track with 30% workforce reduction, expected to yield signi","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/bx7cdeRNxEwazNcDWucEIw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/a0ea1b5efd3fe31259aaba2e79e18980","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/bx7cdeRNxEwazNcDWucEIw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/a0ea1b5efd3fe31259aaba2e79e18980"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/curevac-announces-financial-results-third-122000623.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4080","BK4551","BK4231","CVAC","BK4548","BK4139","CTA","CMO","SITC"],"gpt_icon":1},{"id":"2482795152","title":"HITIQ Limited Strengthens Leadership with New CMO","url":"https://stock-news.laohu8.com/highlight/detail?id=2482795152","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482795152?lang=en_us&edition=fundamental","pubTime":"2024-11-12 08:08","pubTimestamp":1731370086,"startTime":"0","endTime":"0","summary":"HitIQ Limited (AU:HIQ) has released an update. HITIQ Limited has announced the appointment of Chris Davis as the new Chief Marketing Officer, a str...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hitiq-limited-strengthens-leadership-with-new-cmo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hitiq-limited-strengthens-leadership-with-new-cmo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMO"],"gpt_icon":0},{"id":"2482764889","title":"Keurig Dr Pepper names Drew Panayiotou as CMO U.S. Refreshment Beverages","url":"https://stock-news.laohu8.com/highlight/detail?id=2482764889","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482764889?lang=en_us&edition=fundamental","pubTime":"2024-11-12 06:05","pubTimestamp":1731362716,"startTime":"0","endTime":"0","summary":"Keurig Dr Pepper (KDP) announced the appointment of Drew Panayiotou as Chief Marketing Officer or CMO , U.S. Refreshment Beverages, effective Novem...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/keurig-dr-pepper-names-drew-panayiotou-as-cmo-u-s-refreshment-beverages?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/keurig-dr-pepper-names-drew-panayiotou-as-cmo-u-s-refreshment-beverages?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","IE00BJTD4N35.SGD","BK4588","LU1989763427.SGD","BK4585","BK4505","KDP","BK4535","IE00BJTD4V19.USD","BK4177","LU1989763690.USD","CMO"],"gpt_icon":0},{"id":"2482614387","title":"Press Release: Keurig Dr Pepper Appoints Drew Panayiotou as Chief Marketing Officer, U.S. Refreshment Beverages","url":"https://stock-news.laohu8.com/highlight/detail?id=2482614387","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482614387?lang=en_us&edition=fundamental","pubTime":"2024-11-12 06:00","pubTimestamp":1731362400,"startTime":"0","endTime":"0","summary":"BURLINGTON, Mass. and FRISCO, Texas, Nov. 11, 2024. Company elevates digital-first capabilities as part of consumer-obsessed strategy. BURLINGTON, Mass. and FRISCO, Texas, Nov. 11, 2024 /PRNewswire/ -- Keurig Dr Pepper  announced the appointment of Drew Panayiotou as Chief Marketing Officer , U.S. Refreshment Beverages, effective today. Panayiotou brings a modern approach to marketing and a broad range of experience to the role, having led teams at agencies and across multiple industries, including beverages, technology, health care, retail and entertainment.\"I want to recognize Andrew Springate for his more than seven-year tenure as CMO of U.S. Refreshment Beverages,\" continued Archambault. \"Andrew played a key role in elevating the marketing of Dr Pepper and contributing to the incredible growth trajectory of this iconic brand. KDP is fortunate to have his vision, leadership and beverage industry knowledge in this new role.\". As CMO, U.S. Refreshment Beverages, Drew will lead marketi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683348.USD","BK4592","LU0170899867.USD","LU0321505439.SGD","LU0456855351.SGD","BK4177","IE00B19Z3B42.SGD","PFE","BK4534","IE0002270589.USD","BK4535","BK4022","LU0306806265.USD","BK4533","SG9999001176.SGD","BK4581","BK4007","SG9999002232.USD","SG9999011175.SGD","BK4550","LU0225771236.USD","IE00BJTD4V19.USD","R","BK4232","LU0234572021.USD","SG9999001176.USD","LU1057294990.SGD","LU0225284248.USD","LU1989763427.SGD","LU0985481810.HKD","IE00B19Z3581.USD","IE00BJTD4N35.SGD","LU1023059063.AUD","LU0122379950.USD","BK4585","LU0058720904.USD","BK4588","SGXZ57979304.SGD","CMO","BK4568","SG9999003800.SGD","BK4505","LU0289739699.SGD","LU0868494617.USD","LU1066053197.SGD","BK4566","IE00BLSP4239.USD","KDP","IE000M9KFDE8.USD"],"gpt_icon":1},{"id":"2481815793","title":"Press Release: Bolt Projects Reports Q3 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2481815793","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481815793?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:30","pubTimestamp":1731015000,"startTime":"0","endTime":"0","summary":"-- Full year 2024 b-silk revenues are projected to exceed $1 million,propelled by deeper segment penetration and growing customers and. -- For 2025, b-silk revenues are projected to reach at least $4.5 million,cost-per-kilogram produced reduction for b-silk for the year, following. \"This effort has been led by b-silk, a revolutionary biodegradable, film-former polypeptide that offers additional functional benefits for hair care, skin care and color cosmetics,\" said Widmaier. \"Since 2019, B-silk has delivered consistent and proven consumer satisfaction.\". During the third quarter, two new products featuring b-silk -- the Daily Defender SPF30 and the Peak Performance SPF50 -- from Freaks of Nature were introduced to the market, driving higher visibility and deeper penetration in the sunscr","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4090","BK4588","BK4099","CMO","BK4555","03160","BSLK","TM"],"gpt_icon":0},{"id":"2481870191","title":"Tyra Biosciences Reports Third Quarter 2024 Financial Results and Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2481870191","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481870191?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:05","pubTimestamp":1731013500,"startTime":"0","endTime":"0","summary":"- Reported positive interim clinical proof-of-concept results for TYRA-300 in mUC from SURF301 Ph1/2 study -. - IND cleared for Phase 2 study of TYRA-300 in pediatric achondroplasia  -. CARLSBAD, Calif., Nov. 7, 2024 /PRNewswire/ -- Tyra Biosciences, Inc. , a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor  biology, today reported financial results for the quarter ended September30, 2024, and highlighted recent corporate progress.Phase 2IND Submission for NMIBC on Track for Year-End 2024. TYRA plans to expand the clinical development of TYRA-300 into NMIBC to address the unmet needs in this can","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/14NqX0.RJgyZke145_EJTw--~B/aD0xNjQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/38a561c6850218e47560162fca1bdb04","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/14NqX0.RJgyZke145_EJTw--~B/aD0xNjQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/38a561c6850218e47560162fca1bdb04"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/tyra-biosciences-reports-third-quarter-210500284.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tyra-biosciences-reports-third-quarter-210500284.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4533","TYRA","CMO","HCC","BK4121","BK4548","BK4153","LU1093756325.SGD","LU1721428933.USD","BK4213","BK4006","LU0347712357.USD","ACH","LU2413666426.HKD","BK4567","LU1093756168.USD","PR","BK4585","BK4563","MTD","BK4139","BK4503","LU2413666699.HKD","BK4166","QD"],"gpt_icon":0},{"id":"2481836991","title":"PROS Appoints Colleen Langevin as Chief Marketing Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2481836991","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481836991?lang=en_us&edition=fundamental","pubTime":"2024-11-07 22:00","pubTimestamp":1730988000,"startTime":"0","endTime":"0","summary":"Langevin brings proven track record of building strong brands and helping accelerate ARR growth. HOUSTON, November 07, 2024----PROS Holdings, Inc. , a leading provider of AI-powered SaaS pricing and selling solutions, today announced the appointment of Colleen Langevin as Chief Marketing Officer . Langevin brings more than 20 years of experience in driving go-to-market success for B2B and B2C companies, building strong brands and helping to accelerate revenue growth for private and public technology brands.As CMO, Langevin will lead PROS global marketing organization and strategy, with a focus on scaling the demand generation engine as well as driving the next phase of digital marketing transformation. These efforts will enhance brand awareness and further propel the company’s strategic objectives by strengthening customer relationships and attracting new logos to drive impactful revenue growth.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/JWSj2EzLasmlJp6xraSVWw--~B/aD0yMzQ7dz03NjQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/eb5b83ce0c6d18449001f0cd26bde21d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/JWSj2EzLasmlJp6xraSVWw--~B/aD0yMzQ7dz03NjQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/eb5b83ce0c6d18449001f0cd26bde21d"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pros-appoints-colleen-langevin-chief-140000186.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4023","PRO","CMO","PROS"],"gpt_icon":0},{"id":"2481746977","title":"Elanco Animal Health Reports Third Quarter 2024 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2481746977","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481746977?lang=en_us&edition=fundamental","pubTime":"2024-11-07 19:27","pubTimestamp":1730978820,"startTime":"0","endTime":"0","summary":"Revenue of $1,030 million, organic constant currency growth of 1%. Reported Net Income of $364 million, Adjusted Net Income of $66 million. Adjusted EBITDA of $163 million, or 15.8% of Revenue. Pre-tax gain of $640 million from July 2024 divestiture of the aqua business. Tightening full year 2024 financial guidance to reflect current assumptions:. Revenue of $4,420 to $4,450 million, with organic constant currency growth of 3%. Reported Net Income of $286 to $317 million; Reported EPS of $0.58 to $0.64. Received U.S. FDA approval for Zenreliaand Credelio Quattro, bringing innovation to the largest pet health markets. GREENFIELD, Ind., Nov. 7, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated  today reported financial results for the third quarter of 2024, provided guidance for the fourth quarter of 2024, and tightened guidance for the full year 2024.Select Business Highlights Since the Last Earnings Call. Received U.S. FDA approval for Zenrelia, a JAK inhibitor targeting control o","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/WhP3RqSbZbQrD3LfbI_kOg--~B/aD0yNjc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/3e0d7ba65d33b7150e97f71c77abc8af","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/WhP3RqSbZbQrD3LfbI_kOg--~B/aD0yNjc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/3e0d7ba65d33b7150e97f71c77abc8af"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/elanco-animal-health-reports-third-112700841.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/elanco-animal-health-reports-third-112700841.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CMO","BK4561","BK4007","ELAN"],"gpt_icon":0},{"id":"2479012454","title":"BRIEF-Former Microsoft CMO Joins Lumen's Board Of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2479012454","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479012454?lang=en_us&edition=fundamental","pubTime":"2024-10-29 20:36","pubTimestamp":1730205363,"startTime":"0","endTime":"0","summary":"Oct 29 (Reuters) - Lumen Technologies Inc   :   * FORMER MICROSOFT CMO JOINS LUMEN'S BOARD OF DIRECTORSSource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","BK4533","IE00B7KXQ091.USD","IE00BKDWB100.SGD","IE00BJJMRY28.SGD","BK4585","GB00B4QBRK32.GBP","IE0004445239.USD","IE00B19Z9505.USD","IE00BBT3K403.USD","BK4527","IE00BKVL7J92.USD","IE00BKPKM429.USD","IE00B1BXHZ80.USD","IE00BJLML261.HKD","BK4532","BK4587","BK4548","IE00B775SV38.USD","BK4504","BK4525","IE0004086264.USD","BK4581","IE000YTNTUN2.SGD","IE0009G5SDU7.USD","IE00BFSS8Q28.SGD","IE00B3SWFQ91.USD","BK4538","IE00BDCRKT87.USD","GB00B4LPDJ14.GBP","BK4579","BK4566","IE000W1ABFV2.USD","BK4592","BK4567","IE0009356076.USD","IE00BHPRN162.USD","BK4535","IE00BK4W5L77.USD","IE00B1XK9C88.USD","IE000ITXATA3.USD","CMO","IE00B4JS1V06.HKD","BK4089","IE00B4YYXB79.USD","LUMN","IE00B5TLWC47.USD","IE000KEQY171.SGD","IE00B19Z8W00.USD"],"gpt_icon":0}],"pageSize":16,"totalPage":7,"pageCount":4,"totalSize":99}]}}